← All Sponsors
SPONSOR

Instituto Nacional de Cancerologia de Mexico

Total Trials
2
Recruiting
2
Phases
N/A

Instituto Nacional de Cancerologia de Mexico is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Ovarian Neoplasms, Hematologic Neoplasms, Neutropenia.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Instituto Nacional de Cancerologia de Mexico

How many clinical trials has Instituto Nacional de Cancerologia de Mexico sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Instituto Nacional de Cancerologia de Mexico, of which 2 are actively recruiting participants. These trials cover conditions including Ovarian Neoplasms, Hematologic Neoplasms, Neutropenia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Instituto Nacional de Cancerologia de Mexico research focus on?
Instituto Nacional de Cancerologia de Mexico clinical trials span Ovarian Neoplasms, Hematologic Neoplasms, Neutropenia. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Instituto Nacional de Cancerologia de Mexico clinical trial?
To participate in a Instituto Nacional de Cancerologia de Mexico trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Instituto Nacional de Cancerologia de Mexico trials with current recruitment status updated daily.

Clinical Trials by Instituto Nacional de Cancerologia de Mexico

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology